Pure Global AI
NCT06405737Recruitment Completed

Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity

Oxytocin Modulates the Processing of the Advantageous- and Disadvantageous-inequity
University of Electronic Science and Technology of ChinaClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Healthy
Drug/Device/Intervention
Intranasal oxytocin
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University of Electronic Science and Technology of China
Location
Chengdu, China
Timeline & enrollment
Phase
N/A
Start date
Jan 07, 2024
End date
Jun 20, 2024
Enrollment
80 participants
Primary outcome

Behavioral index: fairness rating scores,Behavioral index: preference rating scores,Neural indices: fMRI-based measures of the outcome presentation stage

Summary

The main aim of the study is to investigate whether intranasal oxytocin modulates
 advantageous- and disadvantageous-inequity and whether oxytocin has similar effects on them
 or not.

ICD-10 classifications
ObesitySeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulHealthy person accompanying sick personLifestyle-related conditionMalnutrition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06405737
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06405737 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Electronic Science and Technology of China and is currently Recruitment Completed. The study focuses on Healthy. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.